arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Henry Schein, Inc.

HSIC Health Care Medical Specialities
$89.81
Today
as of Sep 4, 16:50 ET
Last 30 days +4.78% Jul 28 → Sep 04
$84.71 $86.36 $88.01 $89.67 $91.32 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$89.91
High
$90.54
Low
$89.64
Volume
$774,004
Avg Vol
$1M
Mkt Cap
$10.0B
P/E (TTM)
34.70
Beta
—
52w High
$92.18
52w Low
$61.95
Div Yield
—
Shares Out
$112M

Recent Press Releases & News last 60 days · 25 items

Sep 3 · 16:45 Zacks
Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why
Sep 3 · 15:30 Zacks
Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?
Sep 2 · 13:40 Zacks
Is Henry Schein (HSIC) Stock Undervalued Right Now?
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$62
$92
92% of range
Avg surprise (last 3)
+2.3%
Avg reaction (last 2)
+2.6%
100% positive
Latest IV / EM
26%
EM ±4.1% · $90 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.72$0.87$1.02$1.17$1.32 Actual $0.91Actual $1.06Actual $1.05Actual $0.72Actual $0.80Actual $0.78Actual $1.15Est $1.11Actual $1.10Est $1.18Actual $0.84Actual $1.32Est $1.20Actual $0.82 AprJulSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$0$908M$1.8B$2.7B$3.6B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Sat Jun 27, 2026Jun 2026 $0.82 — — — — financials
Tue May 5, 2026Mar/2026 $1.32 $1.20 +10.0% +14.8% +3.3% earnings
Sat Sep 27, 2025Sep 2025 $0.84 — — — — financials
Tue Aug 5, 2025Jun/2025 $1.10 $1.18 -6.8% — — earnings
Mon May 5, 2025Mar/2025 $1.15 $1.11 +3.6% — +2.0% earnings
Sat Sep 28, 2024Sep 2024 $0.78 — — — — financials
Sat Jun 29, 2024Jun 2024 $0.80 — — — — financials
Sat Mar 30, 2024Mar 2024 $0.72 — — — — financials
Sat Sep 30, 2023Sep 2023 $1.05 — — — — financials
Sat Jul 1, 2023Jul 2023 $1.06 — — — — financials
Sat Apr 1, 2023Apr 2023 $0.91 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$3.46B$3.37B—$3.34B$3.24B$3.17B—$3.17B
Cost of revenue$2.36B$2.30B—$2.31B$2.22B$2.17B—$2.18B
Gross profit$1.10B$1.07B—$1.03B$1.02B$1.00B—$993M
Operating income$171M$182M—$164M$151M$175M—$157M
Net income$94M$107M—$101M$86M$110M—$99M
EPS (diluted)$0.82$0.92—$0.84$0.70$0.88—$0.78

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents————————
Inventory$2.06B$2.01B$2.00B$1.91B$1.91B$1.84B$1.81B$1.75B
Total current assets$4.60B$4.50B$4.46B$4.39B$4.24B$4.04B$3.98B$4.15B
Total assets$11.38B$11.30B$11.21B$11.10B$10.91B$10.48B$10.22B$10.61B
Long-term debt————————
Total liabilities$6.66B$6.48B$6.42B$6.20B$6.01B$5.76B$5.38B$5.63B
Total equity$3.16B$3.92B$3.25B$3.36B$4.09B$3.95B$3.39B$4.14B

Implied volatility — last 90 days

18%44%70%96%122% Jun 07 — IV 67% · EM ±9.3%Jun 08 — IV 36% · EM ±4.7%Jun 09 — IV 21% · EM ±2.6%Jun 10 — IV 36% · EM ±4.2%Jun 11 — IV 27% · EM ±3.0%Jun 12 — IV 56% · EM ±5.7%Jun 15 — IV 76% · EM ±5.5%Jun 16 — IV 76% · EM ±4.5%Jun 17 — IV 108% · EM ±4.5%Jun 19 — IV 29% · EM ±6.3%Jun 22 — IV 29% · EM ±6.0%Jun 23 — IV 29% · EM ±5.9%Jun 24 — IV 31% · EM ±6.1%Jun 25 — IV 27% · EM ±5.3%Jun 26 — IV 26% · EM ±5.0%Jun 29 — IV 24% · EM ±4.3%Jun 30 — IV 29% · EM ±4.9%Jul 01 — IV 26% · EM ±4.4%Jul 02 — IV 36% · EM ±5.8%Jul 03 — IV 37% · EM ±5.8%Jul 06 — IV 43% · EM ±5.9%Jul 07 — IV 45% · EM ±6.0%Jul 08 — IV 27% · EM ±3.4%Jul 09 — IV 31% · EM ±3.7%Jul 10 — IV 19% · EM ±2.1%Jul 13 — IV 38% · EM ±3.2%Jul 14 — IV 39% · EM ±2.8%Jul 15 — IV 90% · EM ±5.3%Jul 16 — IV 122% · EM ±5.1%Jul 20 — IV 38% · EM ±9.0%Jul 21 — IV 39% · EM ±9.0%Jul 22 — IV 39% · EM ±8.9%Jul 23 — IV 38% · EM ±8.6%Jul 24 — IV 37% · EM ±8.3%Jul 27 — IV 41% · EM ±8.5%Jul 28 — IV 41% · EM ±8.4%Jul 29 — IV 39% · EM ±7.9%Jul 30 — IV 38% · EM ±7.5%Jul 31 — IV 35% · EM ±6.7%Aug 03 — IV 33% · EM ±5.9%Aug 04 — IV 29% · EM ±5.0%Aug 05 — IV 31% · EM ±5.1%Aug 06 — IV 37% · EM ±5.9%Aug 07 — IV 28% · EM ±4.4%Aug 10 — IV 45% · EM ±6.2%Aug 11 — IV 37% · EM ±4.9%Aug 12 — IV 29% · EM ±3.7%Aug 13 — IV 19% · EM ±2.2%Aug 19 — IV 45% · EM ±2.6%Aug 20 — IV 111% · EM ±4.6%Aug 24 — IV 25% · EM ±5.1%Aug 25 — IV 25% · EM ±5.2%Aug 26 — IV 26% · EM ±5.2%Aug 27 — IV 20% · EM ±4.0%Aug 28 — IV 25% · EM ±4.8%Aug 31 — IV 26% · EM ±4.7%Sep 01 — IV 33% · EM ±5.6%Sep 02 — IV 24% · EM ±4.1%Sep 03 — IV 26% · EM ±4.2%Sep 04 — IV 26% · EM ±4.1%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in